SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-113983
Filing Date
2016-04-26
Accepted
2016-04-26 08:32:14
Documents
6
Period of Report
2016-04-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-9308_18k.htm 8-K 27596
2 EX-10.1 a16-9308_1ex10d1.htm EX-10.1 84963
3 EX-10.2 a16-9308_1ex10d2.htm EX-10.2 81228
4 EX-99.1 a16-9308_1ex99d1.htm EX-99.1 12754
5 GRAPHIC g93081mmi001.gif GRAPHIC 3408
6 GRAPHIC g93081mmi002.jpg GRAPHIC 3788
  Complete submission text file 0001104659-16-113983.txt   217902
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 161590510
SIC: 2834 Pharmaceutical Preparations